Request Submitted
Thanks for your interest in Revli. We review each request to ensure a great fit. If approved, you'll get an email with a secure access link to join.
Request Access
Please tell us a bit about yourself so we can review your request.
Updated List of Top Recently Funded Biotech Startups for 2026
Last update to database: April 27, 2026
Exploring the Best Funded Biotechnology Companies for 2026
The biotechnology industry continues to drive breakthroughs in healthcare and life sciences in 2026, with significant funding pouring into innovative startups across various sectors. Key areas of focus include:
- Bioinformatics: Startups are using big data and AI to accelerate drug discovery and improve patient outcomes.
- Biopharma: Biopharma companies are developing next-generation biologics, vaccines, and personalized therapies, attracting major investments from venture capital firms.
- Genetics and Gene Editing: Advancements in CRISPR technology are enabling startups to push the boundaries of gene editing and precision medicine.
- Biometrics and Wearable Tech: Startups are revolutionizing diagnostics with biometric sensors and wearable devices that offer real-time health monitoring and data-driven insights.
- Life Sciences and Neuroscience: Companies in the neuroscience and life sciences sectors are making strides in medical research and human performance enhancement, driving growth and innovation.
Our weekly updated list covers the most recent funding rounds, major investors, and the emerging biotechnology companies shaping the future of healthcare and life sciences.
Subscribe to Unlock The Latest Funded Startups
Request AccessConnect with founders and decision-makers at recently funded startups. Subscribe to unlock full company and contact data.
Updated List of Top Recently Funded Biotech Startups for 2026
Last update to database: April 27, 2026
Subscribe to Unlock The Latest Funded Startups
Request AccessConnect with founders and decision-makers at recently funded startups. Subscribe to unlock full company and contact data.
Exploring the Best Funded Biotechnology Companies for 2026
The biotechnology industry continues to drive breakthroughs in healthcare and life sciences in 2026, with significant funding pouring into innovative startups across various sectors. Key areas of focus include:
- Bioinformatics: Startups are using big data and AI to accelerate drug discovery and improve patient outcomes.
- Biopharma: Biopharma companies are developing next-generation biologics, vaccines, and personalized therapies, attracting major investments from venture capital firms.
- Genetics and Gene Editing: Advancements in CRISPR technology are enabling startups to push the boundaries of gene editing and precision medicine.
- Biometrics and Wearable Tech: Startups are revolutionizing diagnostics with biometric sensors and wearable devices that offer real-time health monitoring and data-driven insights.
- Life Sciences and Neuroscience: Companies in the neuroscience and life sciences sectors are making strides in medical research and human performance enhancement, driving growth and innovation.
Our weekly updated list covers the most recent funding rounds, major investors, and the emerging biotechnology companies shaping the future of healthcare and life sciences.
Comprehensive Database of Recently Funded Biotech Companies - Updated Weekly
This data is delayed by 4 weeks. Subscribe for instant access to real-time funding rounds and contact data.
|
Company Name
|
Industries | Funding Amount (USD) | Recent Funding Date | Recent Funding Type | Company Headquarters | # Employees | Company Description | Top 5 Investors | Currently Hiring |
|---|---|---|---|---|---|---|---|---|---|
| Vor Bio | Biotechnology, Health Car... | $75M Subscribe to Unlock | March 2026 | Post-IPO Equity | Cambridge, Massachusetts, United States | 160 | Immuno-oncology company d... | RA Capital Management, Qi... | Subscribe to Unlock |
| Avacta Therapeutics | Biotechnology, Health Car... | $13M Subscribe to Unlock | March 2026 | Post-IPO Equity | Wetherby, York, United Kingdom | 41 | Develops technologies, co... | IP Group, Zeus Capital, R... | Subscribe to Unlock |
| Artelo Biosciences | Biotechnology, Life Scien... | $11M Subscribe to Unlock | March 2026 | Post-IPO Equity | La Jolla, California, United States | 6 | Aims to accelerate the de... | Bartosz Lipiński | Subscribe to Unlock |
| Stratum Biosciences | Artificial Intelligence, ... | $2M Subscribe to Unlock | March 2026 | Seed | New York, New York, United States | 10 | Develops therapies design... | Harvard Business School A... | Subscribe to Unlock |
| Olden Labs | Artificial Intelligence, ... | $6M Subscribe to Unlock | March 2026 | Not Specified | South San Francisco, California, United States | 5 | Biotechnology company dev... | Subscribe to Unlock | |
| IceCure Medical | Biotechnology, Health Car... | $4M Subscribe to Unlock | March 2026 | Post-IPO Equity | Caesarea, Hefa, Israel | 64 | Medical device company sp... | Epoch Investment Partners... | Subscribe to Unlock |
| Pulmatrix | Biotechnology, Pharmaceut... | $19M Subscribe to Unlock | March 2026 | Post-IPO Equity | Framingham, Massachusetts, United States | 3 | Develops inhaled therapie... | Polaris Partners, ARCH Ve... | Subscribe to Unlock |
| Terrestrial | Biotechnology, Health Car... | $50M Subscribe to Unlock | March 2026 | Series C | Cambridge, Massachusetts, United States | 61 | Develops biomedical innov... | RA Capital Management, Bi... | Subscribe to Unlock |
| Gradientech | Biotechnology, Health Car... | $5M Subscribe to Unlock | March 2026 | Not Specified | Uppsala, Uppsala Lan, Sweden | 46 | Biotech and diagnostics c... | Almi Invest, EISMEA, CBC ... | Subscribe to Unlock |
| Renovaro Biosciences | Biotechnology, Health Car... | $20M Subscribe to Unlock | March 2026 | Post-IPO Debt | New York, New York, United States | 8 | Biotechnology company dev... | Clemann Group | Subscribe to Unlock |
| OYMotion | Artificial Intelligence, ... | $22M Subscribe to Unlock | March 2026 | Series C | Shanghai, Shanghai, China | 12 | Develops biometric sensor... | GF Xinde Investment Manag... | Subscribe to Unlock |
| Cellbricks Therapeutics | Biotechnology, Life Scien... | $8M Subscribe to Unlock | March 2026 | Seed | Berlin, Berlin, Germany | 30 | Biotech company developin... | VU Venture Partners, ACT ... | Subscribe to Unlock |
| ProteomEdge | Biotechnology, Data & Ana... | $857K Subscribe to Unlock | March 2026 | Not Specified | Stockholm, Stockholms Lan, Sweden | 7 | Develops mass spectrometr... | Navigare Ventures | Subscribe to Unlock |
| Poxel | Biotechnology, Health Dia... | $4M Subscribe to Unlock | March 2026 | Post-IPO Debt | Lyon, Rhone-Alpes, France | 6 | Research-driven pharmaceu... | Bpifrance, OrbiMed, Omnes... | Subscribe to Unlock |
| 3XGenetics | Biotechnology, Genetics, ... | $3M Subscribe to Unlock | March 2026 | Seed | Worcester, Massachusetts, United States | 10 | Develops genetic screenin... | Alumni Ventures | Subscribe to Unlock |
| Epoch Biodesign | Biotechnology | $12M Subscribe to Unlock | March 2026 | Not Specified | London, England, United Kingdom | 55 | Develops enzyme-based sol... | Plug and Play, BoxGroup, ... | Subscribe to Unlock |
| RyboDyn | Biotechnology, Health Car... | $10M Subscribe to Unlock | March 2026 | Seed | San Diego, California, United States | 14 | Biotechnology company dev... | SOSV, Massive Tech Ventur... | Subscribe to Unlock |
| Enlivex | Biotechnology, Health Car... | $21M Subscribe to Unlock | March 2026 | Post-IPO Debt | Ness Ziona, HaMerkaz, Israel | 71 | Clinical-stage immunother... | Korea Investment Partners... | Subscribe to Unlock |
| Turn Therapeutics | Biotechnology, Health Car... | $7M Subscribe to Unlock | March 2026 | Post-IPO Debt | Calabasas, California, United States | 3 | Pharmaceutical company fo... | Avenue Capital Group, The... | Subscribe to Unlock |
| Sernova | Biotechnology, Health Car... | $2M Subscribe to Unlock | March 2026 | Post-IPO Equity | London, Ontario, Canada | 17 | Develops regenerative med... | Gravitas Securities, Fras... | Subscribe to Unlock |
| Aptadel Therapeutics | Biotechnology, Health Car... | $2M Subscribe to Unlock | March 2026 | Seed | Barcelona, Catalonia, Spain | 8 | Pre-clinical biomedical c... | Little Warrior Foundation... | Subscribe to Unlock |
| Secretome Therapeutics | Biotechnology, Health Car... | $250K Subscribe to Unlock | March 2026 | Grant | Dallas, Texas, United States | 14 | Clinical-stage biotechnol... | Parent Project Muscular D... | Subscribe to Unlock |
| Cauldron Ferm | Biotechnology | $13M Subscribe to Unlock | March 2026 | Series A | Orange, New South Wales, Australia | 19 | Develops scalable ferment... | SOSV, Main Sequence Ventu... | Subscribe to Unlock |
| Gilgamesh Pharmaceuticals | Biotechnology, Health Car... | $60M Subscribe to Unlock | March 2026 | Series A | New York, New York, United States | 36 | Biotechnology company dev... | Alumni Ventures, Gaingels... | Subscribe to Unlock |
| Tempest Therapeutics | Biotechnology, Health Car... | $2M Subscribe to Unlock | March 2026 | Post-IPO Equity | San Francisco, California, United States | 24 | Biotechnology company foc... | New Enterprise Associates... | Subscribe to Unlock |
| Diamyd | Biotechnology, Health Dia... | $25M Subscribe to Unlock | March 2026 | Post-IPO Equity | Stockholm, Stockholms Lan, Sweden | 30 | Swedish diabetes company ... | Seven Fleet Capital, RA C... | Subscribe to Unlock |
| ImmuneBridge | Biotechnology, Health Car... | $8M Subscribe to Unlock | March 2026 | Seed | San Francisco, California, United States | 16 | Develops allogeneic immun... | Insight Partners, Gaingel... | Subscribe to Unlock |
| Sol-Gel | Biotechnology, Pharmaceut... | $33M Subscribe to Unlock | March 2026 | Post-IPO Equity | Nes Ziyyona, HaMerkaz, Israel | 34 | Develops a range of speci... | Great Point Partners, Jer... | Subscribe to Unlock |
| Laigo Bio | Biotechnology, Health Car... | $6M Subscribe to Unlock | March 2026 | Seed | Utrecht, Utrecht, The Netherlands | 12 | Uses E3 ligase internaliz... | Kurma Partners, ROM Utrec... | Subscribe to Unlock |
| Humacyte | Biotechnology, Health Car... | $20M Subscribe to Unlock | March 2026 | Post-IPO Equity | Morrisville, North Carolina, United States | 220 | Biotech company developin... | OrbiMed, Avenue Capital G... | Subscribe to Unlock |
| Hansa Biopharma | Biotechnology, Health Car... | $30M Subscribe to Unlock | March 2026 | Post-IPO Debt | Lund, Skane Lan, Sweden | 140 | Biopharmaceutical company... | Redmile Group, Woodline P... | Subscribe to Unlock |
| Consano Bio | Biotechnology, Health Car... | $35M Subscribe to Unlock | March 2026 | Not Specified | Burlington, Massachusetts, United States | 10 | Biotech company developin... | Subscribe to Unlock | |
| Azitra | Biotechnology, Consumer P... | $31M Subscribe to Unlock | March 2026 | Post-IPO Equity | Branford, Connecticut, United States | 12 | Dermatology biotech compa... | National Science Foundati... | Subscribe to Unlock |
| Quantum BioPharma | Biotechnology, Pharmaceut... | $3M Subscribe to Unlock | March 2026 | Post-IPO Equity | Cobourg, Ontario, Canada | 11 | Cannabis production and f... | Cannara Biotech | Subscribe to Unlock |
| Carecubes | Biotechnology, Health Car... | $7M Subscribe to Unlock | March 2026 | Series A | San Francisco, California, United States | 12 | Medical isolation technol... | Betsy Cohen, Lifeforce Ca... | Subscribe to Unlock |
| Numerion Labs | Artificial Intelligence, ... | $20M Subscribe to Unlock | March 2026 | Series D | San Francisco, California, United States | 18 | AI drug discovery platfor... | B Capital, Bill & Melinda... | Subscribe to Unlock |
| Congruence Therapeutics | Biotechnology, Health Car... | $40M Subscribe to Unlock | March 2026 | Not Specified | Montréal, Quebec, Canada | 41 | Biotechnology company foc... | Michael J. Fox Foundation... | Subscribe to Unlock |
| MedicQuant | Biotechnology, Health Car... | $3M Subscribe to Unlock | March 2026 | Seed | Aarhus, Midtjylland, Denmark | 15 | Medical diagnostics equip... | BioInnovation Institute, ... | Subscribe to Unlock |
| Bioliberty | Biotechnology, Health Car... | $8M Subscribe to Unlock | March 2026 | Series A | Edinburgh, Edinburgh, City of, United Kingdom | 28 | Medtech company developin... | Hanna Capital SEZC, Archa... | Subscribe to Unlock |
| Spectral AI | Artificial Intelligence, ... | $32M Subscribe to Unlock | March 2026 | Post-IPO Equity | Dallas, Texas, United States | 78 | AI-driven predictive anal... | Avenue Capital Group, Bio... | Subscribe to Unlock |
| Reviva Pharma | Biopharma, Biotechnology,... | $10M Subscribe to Unlock | March 2026 | Post-IPO Equity | Cupertino, California, United States | 14 | Clinical-stage pharmaceut... | Subscribe to Unlock | |
| Inhibrx | Biotechnology, Life Scien... | $75M Subscribe to Unlock | March 2026 | Post-IPO Debt | La Jolla, California, United States | 160 | Clinical-stage biotech co... | RA Capital Management, Pe... | Subscribe to Unlock |
| Crossbow Therapeutics | Biotechnology, Life Scien... | $77M Subscribe to Unlock | March 2026 | Series B | Cambridge, Massachusetts, United States | 40 | Biotech company developin... | Libbs Ventures, Eli Lilly... | Subscribe to Unlock |
| RenovoRx | Biotechnology, Health Car... | $10M Subscribe to Unlock | March 2026 | Post-IPO Equity | Mountain View, California, United States | 10 | Biotech company developin... | Plug and Play, Boston Sci... | Subscribe to Unlock |
| Cann Group | Biopharma, Cannabis | $533K Subscribe to Unlock | March 2026 | Post-IPO Debt | Mount Waverley, Victoria, Australia | 40 | Cannabis producer and sup... | Sentor Investments, Obsid... | Subscribe to Unlock |
| Atommap | Biopharma, Biotechnology,... | $31M Subscribe to Unlock | March 2026 | Series A | New York, New York, United States | 19 | AI-powered computational ... | Bikui Chen | Subscribe to Unlock |
| Bioxytran | Biotechnology, Health Car... | $1M Subscribe to Unlock | March 2026 | Post-IPO Equity | Needham, Massachusetts, United States | 3 | Biopharmaceutical company... | TRITON FUNDS LLC | Subscribe to Unlock |
| Kupando | Biotechnology | $12M Subscribe to Unlock | March 2026 | Series A | Schönefeld, Brandenburg, Germany | 11 | Biopharmaceutical company... | HTGF (High-Tech Gruenderf... | Subscribe to Unlock |
| Serina Therapeutics | Biopharma, Biotechnology,... | $15M Subscribe to Unlock | March 2026 | Post-IPO Equity | Huntsville, Alabama, United States | 12 | Biotech company developin... | Innovate Alabama, Greg Ba... | Subscribe to Unlock |
| ImmuPharma | Biotechnology, Life Scien... | $10M Subscribe to Unlock | March 2026 | Post-IPO Equity | Westminster, Westminster, United Kingdom | 5 | Drug discovery and develo... | Lanstead Capital | Subscribe to Unlock |
Unlock Company and Contact Data from Recently Funded Startups
Get instant access to founders and decision-makers at recently funded startups. Subscribe now to unlock full company and contact data.
Looking to connect with recently funded startups?
Get access to thousands of founders at recently funded startups each month. Target growth-ready businesses actively seeking new solutions and services.
Other Recently Funded Startups Lists
-
Updated List of Top Recently Funded SaaS Startups for 2025
Updated on April 27, 2026
Read More -
Updated List of Top Recently Funded Crypto and Web3 Startups for 2026
Updated on April 27, 2026
Read More -
Updated List of Top Recently Funded Startups in Europe for 2026
Updated on April 27, 2026
Read More -
Recently Funded Startups in the United States for 2026
Updated on April 27, 2026
Read More
Revli delivers weekly updated databases of recently funded startups and investors, complete with verified contact details, so you can close more deals and raise capital faster.
Copyright© 2025, Revli Inc. All Rights Reserved
Subscribe to Unlock Recently Funded Startup Leads
Connect with founders at startups actively seeking new solutions and services.
Request AccessGet limited preview access with a free account. Subscribe for full access to all leads, funding details and hiring insights.